Nicotine Lozenge 4mg
Natural health product licensed in Canada
- Other names
- AddictAid Lozenge 4mg
- Licence holder
- CellChem Pharmaceuticals Inc.
- NPN or DIN-HM
- 80127009
- Status
- Active licence
- Licence date
- 25 September 2023
- Revision date
- Not provided
- Form
- Pastille
- Route of administration
- Buccale
- Application type
- Générale (non traditionelle)
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| 3-(1-méthyl-2-pyrrolidinyl)pyridine Source : Nicotine polacrilex | 4 mg |
Non-medicinal ingredients
Menthol, Sucralose, Acide citrique, Vert acide n°26, Huile de menthe poivrée, Isomalt
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Pastille | minimum: 1 Tous les jours ; maximum: 16 Tous les jours |
| Adultes | minimum: 18 years | 2 Pastille | minimum: 1 Tous les jours ; maximum: 8 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Nicotine Lozenge can help you stop smoking by reducing withdrawal symptoms. Using Nicotine Lozenge 4mg can enable you to reduce the daily number of cigarettes smoked to ease the transition into a smoke-free lifestyle. Although smoking cessation is preferable, the product can also be used in cases when you need to temporarily refrain from smoking, for example, in smoke-free areas, airplanes, etc. or in other situations when you wish to avoid smoking.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80127009
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.